Skip to main content

Evaluation of the protective effect of verapamil on reperfusion injury by111In anticardiac myosin antibody in canine myocardial infarction

Abstract

We quantitated the protective effect of verapamil on reperfusion injury in canine myocardial infarct using111In-anticardiac myosin antibody and correlated to the electronmicroscopic findings. Experimental myocardial infarction was performed by one hour occlusion of the anterior descending coronary artery and followed by reperfusion. Saline or verapamil (0.6 mg/kg/hr) was started at 40 minutes after coronary artery occlusion and continued throughout the experiment. There was an inverse exponential relationship between anticardiac myosin uptake and regional coronary blood flow in both the control (r=−0.86) and the verapamil treated (r=−0.71) groups. Less uptake of111In-anticardiac myosin antibody was observed in the verapamil treated group than in the control group of the regions where blood flow was lower than 30 % of normal. In the control group, the myocardium showed signs of the typical contraction band necrosis. In the verapamil treated group, however, the myocardium contained fewer electron dense granules and mild degree of contraction bands.

This is a preview of subscription content, access via your institution.

References

  1. Whalen DA, Hamilton DG, Ganote CE, et al: Effect of a transient period of ischemia on myocardial cells: I. Effects on cell volume regulation.Am J Pathol 74: 381–397, 1974

    PubMed  CAS  Google Scholar 

  2. Jennings RB, Ganote CE, Whalen DA: Recent advances in studies on cardiac structure and metabolism. Baltimore, University Park Press, pp 405–413, 1975

    Google Scholar 

  3. Bouchardy B, Majno G: Histopathology of early myocardial infarcts.Am J Pathol 74: 301–330, 1974

    PubMed  CAS  Google Scholar 

  4. Ashraf M, White F, Bloor CM: Ultrastructural influences of reperfusing dog myocardium with calcium-free blood after coronary artery occlusion.Am J Pathol 90: 423–434, 1978

    PubMed  CAS  Google Scholar 

  5. Reimer KA, Lowe JE, Jennings RB: Effect of the calcium antagonist verapamil on necrosis following temporal coronary artery occlusion in dogs.Circulation 55: 581–587, 1977

    PubMed  CAS  Google Scholar 

  6. Kloner RA, Deboer JE, Carlson, et al: The effect of verapamil on myocardial ultrastructure during and following release of coronary artery occlusion.Exp Mol Pathol 36: 277–286, 1982

    PubMed  Article  CAS  Google Scholar 

  7. Wende W, Bleifeld W, Meyer J, et al: Reduction of the size of acute experimental myocardial infarction by verapamil.Basic Res Cardiol 70: 198–208, 1975

    PubMed  Article  CAS  Google Scholar 

  8. Smith HJ, Singh BN, Norris RM, et al: The effect of verapamil on experimental myocardial ischemia with particular reference to regional myocardial blood flow and metabolism.Aust NZ J Med 7: 114–121, 1977

    CAS  Google Scholar 

  9. Lefer AM, Polansky EW, Bianchi CP: Influence of verapamil on cellular integrity and electrolyte concentration of ischemic myocardial tissue in the cat.Basic Res Cardiol 74: 555–567, 1979

    PubMed  Article  CAS  Google Scholar 

  10. Magee PG, Flaherty JT, Bixler TJ, et al: Comparison of myocardial protection with nifedipine and potassium.Circulation 60 (suppl I): 151–157, 1979

    PubMed  CAS  Google Scholar 

  11. Clark RE, Christlieb IY, Henry PD, et al: Nifedifine: A myocardial protective agent.Am J Cardiol 44: 825–831, 1979

    PubMed  Article  CAS  Google Scholar 

  12. Watte JA, Koch CD, LaNoue KF: Effect of Ca antagonism on energy metabolism: Ca and heart function after ischemia.Am J Physiol 238: H909-H916, 1980

    Google Scholar 

  13. Nayer WG, Ferrari R, Williams A: Protective effect of pretreatment on mitochondrial function in ischemic and reperfused myocardium.Am J Cardiol 46: 242–248, 1980

    Article  Google Scholar 

  14. Frame LH, Lopez JA, Khaw BA, et al: Early membrane damage during coronary reperfusion in dogs. Detection by radiolabeled anticardiac myosin F(ab)’2.J Clin Invest 71: 535–544, 1983

    Article  Google Scholar 

  15. Karlsberg RP, Henry PD, Ahmed SA, et al: Lack of protection of ischemic myocardium by verapamil in conscious dog.Eur J Pharmacol 42: 339–346, 1977

    PubMed  Article  CAS  Google Scholar 

  16. Lo H-M, Kloner RA, Braunwald E: Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatment.Am J Cardiol 56: 672–677, 1985

    PubMed  Article  CAS  Google Scholar 

  17. Harbert J, da Rocha AFG. Textbook of nuclear medicine. 2nd ed. Philadelphia: Lea & Febiger; 59–60, 1984

    Google Scholar 

  18. Braunwald E: Symposium on modern thrombolytic therapy.J Am Coll Cardiol 10 (suppl B): 1B-104B, 1987

    Article  Google Scholar 

  19. Puri PS: Contractile and biochemical effects of coronary reperfusion after extended periods of coronary occlusion.Am J Cardiol 36: 244–251, 1975

    PubMed  Article  CAS  Google Scholar 

  20. Kloner RA, Ganote CE, Whalen DA Jr, et al: Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of a reflow.Am J Pathol 74: 399–422, 1974

    PubMed  CAS  Google Scholar 

  21. Jennings RB, Sommers HM, Kaltenbach JP, et al: Electolyte alterations in acute myocardial ischemic injury.Circ Res 14: 260–269, 1964

    PubMed  CAS  Google Scholar 

  22. Lang T-W, Corday E, Gold H, et al: Consequences of reperfusion after coronary occlusion. Effect of hemodynamic and regional myocardial metabolic function.Am J Cardiol 33: 69–81, 1974

    PubMed  Article  CAS  Google Scholar 

  23. Keete DL, Kates RE: Myocardial deposition and cardiac pharmacodynamics of verapamil in the dog.J Pharmocol Exp Ther 220: 91–96, 1982

    Google Scholar 

  24. Festisova TV, Zabolotnyuk IP: Changes in heart muscle and liver proteins in experimental myocardial infarction.Fed Proc 24: T960-T962, 1965

    Google Scholar 

  25. Khaw BA, Beller G A, Haber E, et al: Localization of cardiac myosin specific antibody in myocardial infarction.J Clin Invest 58: 439–446, 1976

    PubMed  Article  CAS  Google Scholar 

  26. Khaw BA, Scott J, Fellon JT, et al: Quantitation by cell sorting initiated with antimyosin fluorescent sphere.Science 217: 1050–1053, 1982

    PubMed  Article  CAS  Google Scholar 

  27. Khaw BA, Beller GA, Habe E: Experimental myocardial infarction imaging following intravenous administration of 131-1 labeled antibody (Fab)’2 fragment specific for cardiac myosin.Circulation 57: 743–750, 1978

    PubMed  CAS  Google Scholar 

  28. Khaw BA, Gold HK, Leinbach RC, et al: Early imaging of experimental myocardial infarction by intracoronary administration of131I-labeled anticardiac myosin (Fab)’2 fragment.Circulation 58: 1137–1142, 1978

    PubMed  CAS  Google Scholar 

  29. Senekowitsch R, Kriegel H, Baum RP, et al: Biokinetic studies and scintigraphic imaging of human carcinoma xenografts with radiolabeled monoclonal antibodies. In Srivastava SC(ed):Radiolabeled monoclonal antibodies for imaging and therapy. New York, Plenum, pp 323–341, 1988

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chung, JK., Lim, S.M., Lee, M.C. et al. Evaluation of the protective effect of verapamil on reperfusion injury by111In anticardiac myosin antibody in canine myocardial infarction. Ann Nucl Med 5, 109–115 (1991). https://doi.org/10.1007/BF03164623

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03164623

Key words

  • myocardial infarction
  • anticardiac myosin antibody
  • verapamil
  • contraction band necrosis